Comparison and discussion of the treatment guidelines for small cell lung cancer
Authors:
Open Access
- 16 May 2018
- journal article
- review article
- Published by Wiley in Thoracic Cancer
- Vol. 9 (7) , 769-774
Abstract
Small cell lung cancer (SCLC), which accounts for 15% to 17% of all lung cancers, is one of the leading causes of cancer‐related death worldwide. More than 130 000 new diagnoses of SCLC and 100 000 deaths from the disease were estimated to have occurred in China in 2013. The existing guidelines of SCLC therapeutic principles differ by region. In recent years, new immunotherapy and targeted therapy treatments have been lacking. In order to understand the current status of SCLC treatment in more detail, we identified the similarities and differences among the latest National Comprehensive Cancer Network Clinical Practice Guidelines for SCLC, the Chinese Society of Clinical Oncology Lung Cancer Guidelines, and the European Society for Medical Oncology Clinical Practice Guidelines for Metastatic SCLC, and present a reference of treatment strategies that should prove beneficial for the treatment of patients with SCLC.Keywords
Funding Information
- National Natural Science Foundation of China (81773207)
- National Science Foundation (16JCZDJC34200, 16PTSYJC00160)
This publication has 25 references indexed in Scilit:
- Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trialThe Lancet Oncology, 2017
- Trends, practice patterns and underuse of surgery in the treatment of early stage small cell lung cancerLung Cancer, 2017
- The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC)Oncotarget, 2017
- Cancer incidence and mortality in China in 2013: an analysis based on urbanization levelChinese Journal of Cancer Research, 2017
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- The role of positron emission tomography in management of small cell lung cancerLung Cancer, 2011
- The IASLC Lung Cancer Staging Project: Data Elements for the Prospective ProjectJournal of Thoracic Oncology, 2009
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999
- Staging and prognostic factors in small cell lung cancer: a consensus reportLung Cancer, 1989